
    
      This study is to determine the toxicity of administering a fludarabine/cyclophosphamide
      (Flu/CY) or busulfan (Bu)/Flu based conditioning regimen followed by allogeneic stem cell
      transplant (AlloSCT) in patients with non-malignant diseases.
    
  